CannLabs, Inc.
CANL · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 12.1% | 4.4% | 4.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 52.1% | 36.5% | 43.4% | 55.8% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 29.8% | 9.6% | 10.9% | 29.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 29.5% | 9.3% | 10.6% | 28.9% |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | 300% | 0% | -75% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |